Top 10 Pharmaceutical Manufacturing Companies in Africa in 2026

10. Emzor Pharmaceutical Industries

• Headquarters:

  Lagos, Nigeria

• Key Focus Areas:

  Analgesics, Antimalarials, Pediatric Formulations, Active Pharmaceutical Ingredients (APIs)

• Estimated Annual Revenue:

  ~$100M – $130M

Emzor Pharmaceutical Industries stands as West Africa’s most iconic domestic drug manufacturer. Founded by Dr. Stella Okoli, Emzor manufactures over 140 healthcare products, with its flagship Emzor Paracetamol holding a near-ubiquitous presence in Nigerian households.

9. Universal Corporation Limited (UCL)

• Headquarters:

  Kikuyu, Kenya

• Key Focus Areas:

  Antiretrovirals (ARVs), Antimalarials, Antibiotics, Essential Generics

• Estimated Annual Revenue:

  ~$110M – $140M

Universal Corporation Limited (UCL) represents East Africa's manufacturing hub. As one of the few pharmaceutical manufacturing plants in Sub-Saharan Africa to earn WHO prequalification for key formulations, UCL plays a key role in supply security for East and Central Africa.

8. Laprophan

• Headquarters:

  Casablanca, Morocco

• Key Focus Areas:

  Gastrointestinal, Anti-inflammatory, Central Nervous System (CNS), OTC Medicines

• Estimated Annual Revenue:

  ~$200M – $250M

A pioneer in North African pharmaceuticals, Laprophan has operated in Morocco for over seven decades. Unlike pure contract packagers, Laprophan has developed a strong R&D culture, holding numerous national and international patents for innovative formulations and drug delivery mechanisms.

7. Biopharm SPA

• Headquarters:

  Algiers, Algeria

• Key Focus Areas:

  Cardiovascular, Metabolic Health, Generics, Contract Manufacturing

• Estimated Annual Revenue:

  ~$300M – $350M

Biopharm SPA is a vertically integrated pharmaceutical force in North Africa, combining domestic manufacturing, logistics, and wholesale distribution. Listed on the Algiers Stock Exchange, the group operates state-of-the-art production sites that adhere to strict European Good Manufacturing Practices (EU-GMP).

6. Saidal Group

• Headquarters:

  Algiers, Algeria

• Key Focus Areas:

  Essential Generics, Insulin, Vaccines, Cardiovascular Drugs

• Estimated Annual Revenue:

  ~$320M – $360M

Saidal Group is Algeria's state-backed pharmaceutical titan. Established to guarantee national health sovereignty, Saidal operates multiple specialized industrial sites across Algeria.

5. EIPICO (Egyptian International Pharmaceutical Industries Co.)

• Headquarters:

  10th of Ramadan City, Egypt

• Key Focus Areas:

  Antibiotics, Ophthalmic Drops, Injectables, Cephalosporins

• Estimated Annual Revenue:

  ~$350M – $400M

EIPICO is Egypt’s largest pharmaceutical exporter, supplying drugs to over 65 countries across Africa, Asia, and Eastern Europe. Operating tens of specialized production lines, EIPICO holds a dominant share of the Egyptian market for sterile injectables, ophthalmics, and antibiotics.

4. Adcock Ingram Holdings

• Headquarters:

  Midrand, South Africa

• Key Focus Areas:

  Critical Care, Hospital Products, Over-The-Counter (OTC) Brands, Generics

• Estimated Annual Revenue:

  ~$480M – $530M

With roots dating back to 1890, Adcock Ingram is one of South Africa's oldest and most deeply rooted healthcare companies. The company holds a commanding market position in South Africa's private OTC segment and is the premier provider of high-volume parenteral solutions (intravenous fluids) and blood-banking products to the public hospital system.

3. EVA Pharma

• Headquarters:

  Giza, Egypt

• Key Focus Areas:

  Oncology, Vaccines, Immunosuppressants, Diabetes Care, Neurosciences

• Estimated Annual Revenue:

  ~$500M – $550M

EVA Pharma is one of the fastest-growing pharmaceutical companies in the Middle East and Africa (MEA) region. Operating multiple state-of-the-art manufacturing facilities, the company produces over a million healthcare units daily.

2. Pharco Corporation

• Headquarters:

  Alexandria, Egypt

• Key Focus Areas:

  Hepatology (Hepatitis C), Anti-infectives, Cardiology, Mass Generics

• Estimated Annual Revenue:

  ~$600M – $700M

Pharco Corporation is a powerhouse in North African healthcare, comprising multi-subsidiary manufacturing facilities near Alexandria. Pharco gained international recognition for its pivotal role in Egypt's historic campaign to eradicate Hepatitis C, producing ultra-low-cost, high-efficacy antiviral generics locally.

1. Aspen Pharmacare Holdings

• Headquarters:

  Durban, South Africa

• Key Focus Areas:

  Injectables, Anaesthetics, Antiretrovirals, Vaccines, Complex Generics

• Estimated Annual Revenue:

  ~$2.2B – $2.5B

Uncontested at the top spot is Aspen Pharmacare, Africa’s largest pharmaceutical manufacturer and a major player in the global generic and sterile injectable markets. Aspen’s world-class manufacturing site in Gqeberha, South Africa, boasts advanced sterile manufacturing capabilities, producing sophisticated biological products, complex vaccines, and anesthetics for global markets.